DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
B cell receptor signaling pathway	R-HSA-983705	map04662	zalcitabine	5327	drug-path
Acute myeloid leukemia	R-HSA-9680350	map05221	zalcitabine	5327	drug-path
ECM-receptor interaction	R-HSA-373711	map04512	zalcitabine	5327	drug-path
MAPK signaling pathway	R-HSA-9652817	map04010	zalcitabine	5327	drug-path
Small cell lung cancer	R-HSA-5619066	map05222	zalcitabine	5327	drug-path
Graft-versus-host disease	R-HSA-1643685	map05332	butamben	2482	drug-path
Hematopoietic cell lineage	R-HSA-173752	map04640	butamben	2482	drug-path
Autoimmune thyroid disease	R-HSA-1643685	map05320	butamben	2482	drug-path
Asthma	R-HSA-444620	map05310	butamben	2482	drug-path
Chemokine signaling pathway	R-HSA-168638	map04062	butamben	2482	drug-path
Allograft rejection	R-HSA-9679028	map05330	butamben	2482	drug-path
Long-term depression	R-HSA-9620244	map04730	butamben	2482	drug-path
Type I diabetes mellitus	R-HSA-5683209	map04940	butamben	2482	drug-path
Antigen processing and presentation	R-HSA-1236975	map04612	butamben	2482	drug-path
Olfactory transduction	R-HSA-9751605	map04740	butamben	2482	drug-path
Cell adhesion molecules (CAMs)	R-HSA-1031690	0	butamben	2482	drug-path
Graft-versus-host disease	R-HSA-1643685	map05332	lisinopril	5362119	drug-path
Autoimmune thyroid disease	R-HSA-1643685	map05320	lisinopril	5362119	drug-path
Olfactory transduction	R-HSA-9751605	map04740	lisinopril	5362119	drug-path
Asthma	R-HSA-444620	map05310	lisinopril	5362119	drug-path